FDA has safety concerns with Merck insomnia drug

Home › FDA has safety concerns with Merck insomnia drug

The Food and Drug Administration on Monday released its review of the company's sleep aid, suvorexant, ahead of a public meeting on Wednesday.

05.11	Vodafone-Three merger could get green light, watchdog says
05.11	Altice USA residential video RGUs down 77,000 in 3Q 2024
05.11	Shoppers warned over luxury advent calendar scams
05.11	Durable Floor Coating from HMG Paints Transforms FC United\'s SMRE Bar
05.11	Teknos Poland Honored by Farby i Lakiery
05.11	Xumo teams up with Target to offer Hisense Xumo TVs
05.11	KT launches 8K AI-powered IPTV set-top box
05.11	Tropical Storm Rafael Graphics
More »

je.st